Assessment of global coagulation function under treatment with emicizumab concomitantly with bypassing agents in haemophilia A with inhibitor (UNEBI Study): multicentre open-label non-randomised clinical trial

• Takashi Suzuki,
• Kenji Nishio,
• Tadashi Matsushita,
• Kenichi Ogiwara,
• Masashi Taki,
• Hideyuki Takedani,
• Kagehiro Amano,
• Masanori Matsumoto,
• Midori Shima,
• Masato Kasahara,
• Keiji Nogami

Affiliations

Takashi Suzuki

Blood Coagulation, Medical Corporation Foundation Ogikubo Hospital, Suginami-ku, Japan

Kenji Nishio

General Medicine, Nara Medical University, Kashihara, Japan

Tadashi Matsushita

Blood Transfusion Service, Nagoya University Hospital, Nagoya, Japan

Kenichi Ogiwara

Pediatrics, Nara Medical University, Kashihara, Japan

Masashi Taki

Pediatrics, Sei Marianna University School of Medicine Yokohama Seibu Hospital, Yokohama, Japan

Hideyuki Takedani

Joint Surgery, IMSUT Hospital, Minato-ku, Japan

Kagehiro Amano

Laboratory Medicine, Tokyo Medical University, Shinjuku-ku, Japan

Masanori Matsumoto

Blood Transfusion Medicine, Nara Medical University, Kashihara, Japan

Midori Shima

Pediatrics, Nara Medical University, Kashihara, Japan

Masato Kasahara

Institute for Clinical and Translational Science, Nara Medical University, Kashihara, Japan

Keiji Nogami

Pediatrics, Nara Medical University, Kashihara, Japan